BBA , Finance

Larry G Stambaugh is the Chief Executive Officer and President of Calando Pharmaceuticals, Inc, a company developing cancer therapeutics using RNAi technology. He has also practiced as a principal at Apercu Consulting, where he serves as an advisor to private and public boards and management. During his more than 35-year career Mr. Stambaugh has faced and solved many of the toughest business problems that can challenge a company. As a top executive his visionary leader has built management teams and companies around “A humble heart and an open mind”. He has led the turnaround of organizations through setting strategic initiatives with the board and management for new directions and priorities. His well developed process has effectively guided the board and management to realistically access their strengths and weakness and direct the organization into new businesses and discontinue underperforming activities and business units. Mr. Stambaugh has raised nearly $400 million of capital in private and public financing. He has taken a company public in both the U.S. and Europe. In times of weak financing markets he has found creative alternatives for financing including, PIPE transactions, syndicated bank loans, reverse mergers, corporate collaborations and private equity funding. Well ahead of his time, Mr. Stambaugh has had a focus on board activities and corporate governance practices for nearly three decades. He has more than 75 years of board service and speaks on the best practices and current issues in corporate governance. In 2002, 2006 and for an unprecedented time in 2007 he was awarded the “Director of the Year” recognition for his work in corporate governance leadership and education. He has served on numerous boards and worked with many other boards and their directors.